APRI Apricus Biosciences, Inc.

-0.01  -1%
Previous Close 0.97
Open 0.97
Price To book 0.00
Market Cap 7.43M
Shares 7,741,000
Volume 234,812
Short Ratio 3.56
Av. Daily Volume 439,024

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

NDA resubmission planned for 3Q 2017.
Erectile dysfunction
Phase 2b planned - seeking partnership.
Secondary Raynaud's Phenomenon